- To take the test online, go to our secure Web site at http://www.nursingcenter.com/ce/ajn . View instructions for taking the test online there.
- If you prefer to submit your test by mail, record your answers in the test answer section of the CE enrollment form below. Each question has only one correct answer. You may make copies of the form.
- Complete the registration information and course evaluation. Mail the completed enrollment form and registration fee to: Lippincott Professional Development, CE Group, 74 Brick Blvd., Bldg. 4, Suite 206, Brick, NJ 08723. You will receive your certificate in four to six weeks. For faster service, include a fax number and we will fax your certificate within two business days of receiving your enrollment form. You will receive your CE certificate of earned contact hours and an answer key to review your results. There is no minimum passing grade.
- Registration deadline is June 5, 2020.
DISCOUNTS AND CUSTOMER SERVICE
- Send in together two or more tests from any nursing journal published by Lippincott Professional Development (LPD), and deduct $0.95 from the price of each test.
- We also offer CE accounts for hospitals and other health care facilities online at www.nursingcenter.com. Call 1-800-787-8985 for details.
LPD will award the number of contact hours indicated for each continuing nursing education activity. LPD is accredited as a provider of continuing nursing education by the Commission on Accreditation of the American Nurses Credentialing Center.
These activities are also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for the number of contact hours indicated. LPD is also an approved provider of continuing nursing education by the District of Columbia, Georgia, and Florida #50-1223.
Breast Cancer Screening: A Review of Current Guidelines
To provide information about current breast cancer screening guidelines.
After completing this continuing education activity, you should be able to
- outline the current guidelines and the rationales supporting them.
- identify controversies surrounding these guidelines.
- discuss the benefits and risks of breast cancer screening.
- Breast cancer affects about what percentage of U.S. women during their lifetimes?
- Which of the following is one of the 2 most significant risk factors for breast cancer?
- advancing age
- breast density
- early menarche
- Tomosynthesis is
- contrast-enhanced digital mammography.
- a new ultrasonic imagery technique.
- three-dimensional mammography.
- Women are considered to be at moderate risk for breast cancer if their lifetime risk is
- 10% to 15%.
- 15% to 20%.
- 20% to 25%.
- The ability of mammography to correctly identify people who do not have breast cancer is called
- False-positive mammogram results are common, particularly among women in their
- The only breast cancer screening method proven to reduce mortality is
- magnetic resonance imaging (MRI).
- A randomized controlled trial found that the introduction of patient education and emotional support reduced patient anxiety prior to mammography by what percentage?
- The American Cancer Society (ACS) strongly recommends that women at average risk for developing breast cancer begin regular screening mammography at age
- Qualified recommendations from the ACS include
- annual screening for women ages 40 to 49.
- biennial or annual screening for women ages 55 and older.
- the opportunity to begin annual screening at age 35.
- In 2016, the U.S. Preventive Services Task Force (USPSTF) determined that the net benefit of mammography screening in women ages 40 to 49 was
- To provide the best overall balance of benefits versus harms, the USPSTF concluded that biennial mammography screening is appropriate for most women ages 50 to
- The USPSTF concluded there was insufficient evidence that adding imaging modalities to mammography screening provided additional benefits in women at average risk who have
- dense breasts.
- had previous breast biopsies.
- a family history of breast cancer.
- Current National Comprehensive Cancer Network (NCCN) guidelines recommend that women at average risk for developing breast cancer begin screening mammography at age
- Mammography can detect a breast lesion how long before a clinical breast examination can?
- 6 months
- 1 year
- 2 years
- Both the ACS and the NCCN recommend yearly mammography and MRI for women at high risk, generally starting at age
- The Tyrer–Cuzick model for quantifying breast cancer risk bases its estimate on several factors, one of which is
- onset of menarche.
- history of breast biopsies.
- the presence of BRCA gene mutations.
- Which of the following statements about men at high risk for breast cancer is inaccurate?
- These men should have a yearly clinical breast examination.
- These men should have breast imaging annually.
- These men should also follow prostate screening guidelines.
- According to the NCCN, how often should women 25 to 39 years of age have a clinical breast examination?
- every year
- every 1 to 3 years
- every 3 to 5 years